“Universal Flu Vaccine”: Can NK Cell-mediated ADCC Tip the Scales?

by Maya Hassane, Christophe Paget
Published 2016-06-01

T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine

by Anna Schmidt, Dennis Lapuente
Published 2021-01-01

B cells and functional antibody responses to combat influenza

by Giuseppe eLofano, Giuseppe eLofano, Giuseppe eLofano, Arun eKumar, Oretta eFinco, Giuseppe eDel Giudice, Sylvie eBertholet
Published 2015-06-01

Novel Platforms for the Development of a Universal Influenza Vaccine

by Arun Kumar, Arun Kumar, Trine Sundebo Meldgaard, Trine Sundebo Meldgaard, Sylvie Bertholet, Sylvie Bertholet
Published 2018-03-01

Plant-Expressed Recombinant Universal Influenza A Vaccine Candidates

Published 2019

Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections

by Origène Nyanguile
Published 2019-06-01

Abstract P-36: HBc4M2e Virus-Like Particles for Influenza A Vaccine Development: a Cryo-EM Study

by Alexey V. Shvetsov, Evgeny B. Pichkur, Tatiana A. Shtam, Vladimir V. Egorov, Liudmila M. Tsybalova, Liudmila A. Stepanova, Aram A. Shaldzhyan, Yana A. Zabrodskaya
Published 2019-06-01

Survey of Conservative Epitopes Existed on Type A Influenza Viruses for Vaccine Design

by Zong-Ci Liu, 劉宗祺
Published 2011

MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.

by James S Testa, Vivekananda Shetty, Julie Hafner, Zacharie Nickens, Shivali Kamal, Gomathinayagam Sinnathamby, Ramila Philip
Published 2012-01-01

Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.

by Hamidreza Hashemi, Somayeh Pouyanfard, Mojgan Bandehpour, Zahra Noroozbabaei, Bahram Kazemi, Xavier Saelens, Talat Mokhtari-Azad
Published 2012-01-01

Evaluation Influenza Vaccination Effectiveness and Cost-Benefit for Working Adults

by Wei-Yi Yang, 楊維怡
Published 2010

Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study.

by Kamonthip Rungrojcharoenkit, Panya Sunintaboon, Damon Ellison, Louis Macareo, Panuwat Midoeng, Preamrudee Chaisuwirat, Stefan Fernandez, Sukathida Ubol
Published 2020-01-01

A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice

by Susan Thrane, Kara-Lee Aves, Ida E. M Uddbäck, Christoph M. Janitzek, Julianna Han, Yuhe R. Yang, Andrew B. Ward, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Allan R. Thomsen, Jan P. Christensen, Adam F. Sander
Published 2020-07-01

Design of Influenza Immunogens by Hemagglutinin (HA) Protein Minimization

by Mallajosyula, V Vamsee Aditya
Published 2018

Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes

by Liudmila A. Stepanova, Eugenia S. Mardanova, Marina A. Shuklina, Elena A. Blokhina, Roman Y. Kotlyarov, Marina V. Potapchuk, Anna A. Kovaleva, Inna G. Vidyaeva, Alexandr V. Korotkov, Elizaveta I. Eletskaya, Nikolai V. Ravin, Liudmila M. Tsybalova
Published 2018-04-01

EFFECTIVENESS OF CROSS-PROTECTIVE RECOMBINANT INFLUENZA VACCINE BASED ON CONSERVED EPITOPES OF VIRAL PROTEINS М2 AND HEMAGGLUTININ

by L. A. Stepanova, M. A. Shuklina, E. A. Blokhina, R. Y. Kotlyarov, A. A. Kovaleva, N. V. Ravin, L. M. Tsybalova
Published 2018-01-01